Every large-scale population health study presents complex data challenges for researchers to overcome. From cohort management to data acquisition and interpretation, discovering actionable insights can be elusive for even the most experienced researcher.
Taking an already challenging model and introducing additional datasets does not come without risk, but with the correct preparation and support, large-scale population-based integrative-omics can lead to crucial new discoveries that deepen the understanding of human biology and disease—and it is more approachable than ever before.
In this double-feature webinar, we introduce you to two leading experts in neuroscience and respiratory disease research, leveraging integrative-omics technologies to uncover new insights. We discuss their recent research in Alzheimer’s disease and chronic obstructive pulmonary disease (COPD) and outline their recommendations for building successful integrative-omics models, leveraging metabolomics technology to accelerate research objectives.
You will learn:
- How to approach integrative-omics study design
- The functional benefit of metabolomics in multiomics research
- How to gain insights from metabolomics data integration in large cohorts
- How to identify actionable outcomes from nontargeted metabolomics data.
- Novel discoveries in Alzheimer’s disease research
- Novel discoveries in COPD research
Speakers
Katerina Kechris, Ph.D.
Daniel Panyard, Ph.D.
Micaiah Ward, Ph.D.
Offered Free by: Metabolon
See All Resources from: Metabolon
